Cargando…
FBP1 promotes ovarian cancer development through the acceleration of cell cycle transition and metastasis
Epithelial ovarian cancer (EOC) is the fifth most common malignancy in women, with a 5-year mortality of >70% in North America. As the symptoms are often not observed until the cancer has spread extensively, few women are diagnosed at an early stage of disease. Large-scale gene expression analyse...
Autores principales: | Xiong, Xifeng, Zhang, Jinli, Hua, Xing, Cao, Wenjuan, Qin, Shengnan, Dai, Libing, Liu, Wei, Zhang, Zhi, Li, Xiaojian, Liu, Zhihe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036457/ https://www.ncbi.nlm.nih.gov/pubmed/30008853 http://dx.doi.org/10.3892/ol.2018.8872 |
Ejemplares similares
-
Knockdown of FUSE binding protein 1 enhances the sensitivity of epithelial ovarian cancer cells to carboplatin
por: Zhang, Jinli, et al.
Publicado: (2017) -
FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3
por: Xiong, Xifeng, et al.
Publicado: (2022) -
Amentoflavone triggers cell cycle G2/M arrest by interfering with microtubule dynamics and inducing DNA damage in SKOV3 cells
por: Zhang, Jinli, et al.
Publicado: (2020) -
Fibrochondrogenic differentiation potential of tendon-derived stem/progenitor cells from human patellar tendon
por: Qin, Shengnan, et al.
Publicado: (2019) -
High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity
por: Liu, Wei, et al.
Publicado: (2020)